Park Avenue Securities’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.84M | Buy |
15,362
+23
| +0.1% | +$10.2K | 0.06% | 223 |
|
|
2025
Q1 | $7.44M | Buy |
15,339
+885
| +6% | +$429K | 0.09% | 157 |
|
|
2024
Q4 | $5.82M | Buy |
14,454
+467
| +3% | +$188K | 0.06% | 220 |
|
|
2024
Q3 | $6.51M | Sell |
13,987
-12
| -0.1% | -$5.58K | 0.07% | 181 |
|
|
2024
Q2 | $6.56M | Sell |
13,999
-240
| -2% | -$112K | 0.08% | 174 |
|
|
2024
Q1 | $5.95M | Buy |
14,239
+1,097
| +8% | +$459K | 0.08% | 176 |
|
|
2023
Q4 | $5.35M | Buy |
13,142
+2,661
| +25% | +$1.08M | 0.07% | 175 |
|
|
2023
Q3 | $3.65M | Sell |
10,481
-452
| -4% | -$157K | 0.06% | 209 |
|
|
2023
Q2 | $3.85M | Buy |
10,933
+742
| +7% | +$261K | 0.06% | 203 |
|
|
2023
Q1 | $3.21M | Buy |
10,191
+1,513
| +17% | +$477K | 0.06% | 206 |
|
|
2022
Q4 | $2.51M | Buy |
8,678
+863
| +11% | +$249K | 0.04% | 246 |
|
|
2022
Q3 | $2.26M | Buy |
7,815
+105
| +1% | +$30.4K | 0.05% | 234 |
|
|
2022
Q2 | $2.17M | Sell |
7,710
-1,159
| -13% | -$327K | 0.04% | 253 |
|
|
2022
Q1 | $2.32M | Buy |
8,869
+3,041
| +52% | +$794K | 0.04% | 251 |
|
|
2021
Q4 | $1.28M | Sell |
5,828
-1,023
| -15% | -$225K | 0.02% | 376 |
|
|
2021
Q3 | $1.24M | Sell |
6,851
-4,314
| -39% | -$783K | 0.03% | 346 |
|
|
2021
Q2 | $2.25M | Sell |
11,165
-378
| -3% | -$76.2K | 0.05% | 208 |
|
|
2021
Q1 | $2.48M | Buy |
11,543
+4,661
| +68% | +$1M | 0.06% | 169 |
|
|
2020
Q4 | $1.63M | Buy |
6,882
+1,959
| +40% | +$463K | 0.05% | 189 |
|
|
2020
Q3 | $1.34M | Buy |
4,923
+790
| +19% | +$215K | 0.04% | 183 |
|
|
2020
Q2 | $1.2M | Buy |
4,133
+245
| +6% | +$71.1K | 0.05% | 163 |
|
|
2020
Q1 | $925K | Buy |
3,888
+436
| +13% | +$104K | 0.08% | 86 |
|
|
2019
Q4 | $756K | Sell |
3,452
-12
| -0.3% | -$2.63K | 0.03% | 222 |
|
|
2019
Q3 | $587K | Buy |
3,464
+121
| +4% | +$20.5K | 0.03% | 224 |
|
|
2019
Q2 | $613K | Buy |
+3,343
| New | +$613K | 0.07% | 102 |
|